Cover

Glaucoma Surgery

Editor(s): Bettin P. (Milan) 
Khaw P.T. (London) 
Table of Contents
Vol. 50, 2012
Section title: Paper
Bettin P, Khaw PT (eds): Glaucoma Surgery. Dev Ophthalmol. Basel, Karger, 2012, vol 50, pp 173–183
(DOI:10.1159/000334800)

When Should We Give Up Filtration Surgery: Indications, Techniques and Results of Cyclodestruction

Huang G. · Lin S.C.
aDepartment of Ophthalmology, University of California, San Francisco, Calif., USA; bState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, and cDepartment of Ophthalmology, The Third Affiliated Hospital of Nanchang University, Nanchang, China

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Purpose: Cyclodestructive procedures are traditionally used in cases of glaucoma that are refractory to medical and surgical therapy. The goal of this chapter is to describe indications, contraindications, techniques, and pitfalls of cyclodestructive procedures including transscleral cyclophotocoagulation (TCP) and endoscopic cyclophotocoagulation (ECP). Methods: A literature search for cyclophotocoagulation was performed. Relevant studies were included for evaluation and review. Results: It is encouraging that TCP seems relatively efficacious even for patients who have been refractory to other treatments, depending on the energy setting, follow-up period, and definition of success. Repeated TCP is often required. TCP was more often used in eyes with limited visual potential caused by severe forms of glaucoma than in eyes with good visual potential. Serious complications were significant vision loss, inflammation, hypotony, and phthisis. ECP came later into clinical use for the treatment of refractory glaucoma. ECP is able to specifically target the ciliary epithelium under direct viewing as compared to TCP, which is an indirect cyclodestructive procedure. In the literature, it has been demonstrated that ECP has overall good success with relatively low complication rates when used for adult forms of glaucoma. There appeared to be a tendency to perform ECP earlier when combined with cataract surgery for controlling intraocular pressure. Serious complications of ECP were hypotony-related disorders, macular edema, and choroidal and retinal detachment. Recent publications have shown that both TCP and ECP may be reasonable first-line surgeries or even first-line treatments. Conclusions: Both TCP and ECP are effective cyclodestructive procedures and alternatives for the treatment of glaucoma refractory to medical and surgical therapy, though potential for serious complications exists. Recent studies have indicated that TCP and ECP are used increasingly as the primary surgery for various kinds and stages of glaucoma.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Bietti G: Surgical intervention on the ciliary body; new trends for the relief of glaucoma. J Am Med Assoc 1950;142:889-897
  2. Meyer SJ: Diathermy cauterization of ciliary body for glaucoma. Am J Ophthalmol 1948;31:1504-1506
  3. Weekers L, Weekers R: Nonperforating thermometric cyclodiathermy in treatment of hypertensive uveitis. Arch Ophthalmol 1948;39:509-517
  4. Walton DS, Grant WM: Penetrating cyclodiathermy for filtration. Arch Ophthalmol 1970;83:47-48
  5. Coleman DJ, Lizzi FL, Driller J, et al: Therapeutic ultrasound in the treatment of glaucoma. I. Experimental model. Ophthalmology 1985;92:339-346
  6. Wilensky JT: Staphyloma formation as a complication of ultrasound treatment in glaucoma. Arch Ophthalmol 1985;103:1113
  7. Coleman DJ, Lizzi FL, Driller J, et al: Therapeutic ultrasound in the treatment of glaucoma. II. Clinical applications. Ophthalmology 1985;92:347-353
  8. De Roetth A, Jr: Cryosurgery for the treatment of advanced chronic simple glaucoma. Am J Ophthalmol 1968;66:1034-1041
  9. De Roetth A, Jr: Cryosurgery for the treatment of advanced chronic simple glaucoma. Trans Am Ophthalmol Soc 1968;66:45-61
  10. Bellows AR, Grant WM: Cyclocryotherapy in advanced inadequately controlled glaucoma. Am J Ophthalmol 1973;75:679-684
  11. Bellows AR, Grant WM: Cyclocryotherapy of chronic open-angle glaucoma in aphakic eyes. Am J Ophthalmol 1978;85:(5 Pt 1)615-621
  12. Caprioli J, Strang SL, Spaeth GL, Poryzees EH: Cyclocryotherapy in the treatment of advanced glaucoma. Ophthalmology 1985;92:947-954
  13. Beckman H, Kinoshita A, Rota AN, Sugar HS: Transscleral ruby laser irradiation of the ciliary body in the treatment of intractable glaucoma. Trans Am Acad Ophthalmol Otolaryngol 1972;76:423-436
  14. Beckman H, Sugar HS: Neodymium laser cyclocoagulation. Arch Ophthalmol 1973;90:27-28
  15. Devenyi RG, Trope GE, Hunter WH, Badeeb O: Neodymium:YAG transscleral cyclocoagulation in human eyes. Ophthalmology 1987;94:1519-1522
  16. Devenyi RG, Trope GE, Hunter WS: Neodymium-YAG transscleral cyclocoagulation in rabbit eyes. Br J Ophthalmol 1987;71:441-444
  17. McAllister J, O'Brien C: Neodymium:YAG transscleral cyclocoagulation: a clinical study. Eye (Lond) 1990;4:(Pt5)651-656
  18. Hampton C, Shields MB, Miller KN, Blasini M: Evaluation of a protocol for transscleral neodymium:YAG cyclophotocoagulation in one hundred patients. Ophthalmology 1990;97:910-917
  19. Wright MM, Grajewski AL, Feuer WJ: Nd:YAG cyclophotocoagulation: outcome of treatment for uncontrolled glaucoma. Ophthalmic Surg 1991;22:279-283
  20. Delgado MF, Dickens CJ, Iwach AG, et al: Long-term results of noncontact neodymium:yttrium-alumi-numgarnet cyclophotocoagulation in neovascular glaucoma. Ophthalmology 2003;110:895-899
  21. Lin P, Wollstein G, Glavas IP, Schuman JS: Contact transscleral neodymium:yttrium-aluminum-garnet laser cyclophotocoagulation Long-term outcome. Ophthalmology 2004;111:2137-2143
  22. Noureddin BN, Wilson-Holt N, Lavin M, et al: Advanced uncontrolled glaucoma. Nd:YAG cyclophotocoagulation or tube surgery. Ophthalmology 1992;99:430-436discussion 7
  23. Simmons RB, Shields MB, Blasini M, et al: Transscleral Nd:YAG laser cyclophotocoagulation with a contact lens. Am J Ophthalmol 1991;112:671-677
  24. Echelman DA, Stern RA, Shields SR, et al: Variability of contact transscleral neodymium:YAG cyclophotocoagulation. Invest Ophthalmol Vis Sci 1995;36:497-502
  25. Shields MB, Shields SE: Noncontact transscleral Nd:YAG cyclophotocoagulation: a long-term follow-up of 500 patients. Trans Am Ophthalmol Soc 1994;92:271-283discussion 83-87
  26. Brancato R, Giovanni L, Trabucchi G, Pietroni C: Contact transscleral cyclophotocoagulation with Nd:YAG laser in uncontrolled glaucoma. Ophthalmic Surg 1989;20:547-551
  27. Schuman JS, Puliafito CA, Allingham RR, et al: Contact transscleral continuous wave neodymium: YAG laser cyclophotocoagulation. Ophthalmology 1990;97:571-580
  28. Schuman JS, Jacobson JJ, Puliafito CA, et al: Experimental use of semiconductor diode laser in contact transscleral cyclophotocoagulation in rabbits. Arch Ophthalmol 1990;108:1152-1157
  29. Schuman JS, Bellows AR, Shingleton BJ, et al: Contact transscleral Nd:YAG laser cyclophotocoagulation. Midterm results. Ophthalmology 1992;99:1089-1094discussion 95
  30. Mankowska A, Zagorski Z, Kawa P, Mackiewicz J: Diode laser trans-scleral cyclo-photo-coagulation (in Polish). Klin Oczna 1999;101:103-104
  31. Rotchford AP, Jayasawal R, Madhusudhan S, et al: Transscleral diode laser cycloablation in patients with good vision. Br J Ophthalmol 2010;94:1180-1183
  32. Spencer AF, Vernon SA: ‘Cyclodiode’: results of a standard protocol. Br J Ophthalmol 1999;83:311-316
  33. Pucci V, Tappainer F, Borin S, Bellucci R: Long-term follow-up after transscleral diode laser photocoagulation in refractory glaucoma. Ophthalmologica 2003;217:279-283
  34. Schlote T, Grub M, Kynigopoulos M: Long-term results after transscleral diode laser cyclophotocoagulation in refractory posttraumatic glaucoma and glaucoma in aphakia. Graefes Arch Clin Exp Ophthalmol 2008;246:405-410
  35. Leszczynski R, Gierek-Lapinska A, Forminska-Kapuscik M: Transscleral cyclophotocoagulation in the treatment of secondary glaucoma. Med Sci Monit 2004;10:CR542-CR548
  36. Murphy CC, Burnett CA, Spry PG, et al: A two centre study of the dose-response relation for transscleral diode laser cyclophotocoagulation in refractory glaucoma. Br J Ophthalmol 2003;87:1252-1257
  37. Hauber FA, Scherer WJ: Influence of total energy delivery on success rate after contact diode laser transscleral cyclophotocoagulation: a retrospective case review and meta-analysis. J Glaucoma 2002;11:329-333
  38. Noureddin BN, Zein W, Haddad C, et al: Diode laser transcleral cyclophotocoagulation for refractory glaucoma: a 1 year follow-up of patients treated using an aggressive protocol. Eye (Lond) 2006;20:329-335
  39. Kosoko O, Gaasterland DE, Pollack IP, Enger CL: Long-term outcome of initial ciliary ablation with contact diode laser transscleral cyclophotocoagulation for severe glaucoma. The Diode Laser Ciliary Ablation Study Group. Ophthalmology 1996;103:1294-1302
  40. Ansari E, Gandhewar J: Long-term efficacy and visual acuity following transscleral diode laser photocoagulation in cases of refractory and non-refractory glaucoma. Eye (Lond) 2007;21:936-940
  41. Youn J, Cox TA, Herndon LW, et al: A clinical comparison of transscleral cyclophotocoagulation with neodymium:YAG and semiconductor diode lasers. Am J Ophthalmol 1998;126:640-647
  42. Lee PF: Argon laser photocoagulation of the ciliary processes in cases of aphakic glaucoma. Arch Ophthalmol 1979;97:2135-2138
  43. Lee PF, Shihab Z, Eberle M: Partial ciliary process laser photocoagulation in the management of glaucoma. Lasers Surg Med 1980;1:85-92
  44. Uram M: Ophthalmic laser microendoscope ciliary process ablation in the management of neovascular glaucoma. Ophthalmology 1992;99:1823-1828
  45. Uram M: Combined phacoemulsification, endoscopic ciliary process photocoagulation, and intraocular lens implantation in glaucoma management. Ophthalmic Surg 1995;26:346-352
  46. Chen J, Cohn RA, Lin SC, et al: Endoscopic photo-coagulation of the ciliary body for treatment of refractory glaucomas. Am J Ophthalmol 1997;124:787-796
  47. Gayton JL, Van Der Karr M, Sanders V: Combined cataract and glaucoma surgery: trabeculectomy versus endoscopic laser cycloablation. J Cataract Refract Surg 1999;25:1214-1219
  48. Lima FE, Magacho L, Carvalho DM, et al: A prospective, comparative study between endoscopic cyclophotocoagulation and the Ahmed drainage implant in refractory glaucoma. J Glaucoma 2004;13:233-237
  49. Neely DE, Plager DA: Endocyclophotocoagulation for management of difficult pediatric glaucomas. J AAPOS 2001;5:221-229
  50. Plager DA, Neely DE: Intermediate-term results of endoscopic diode laser cyclophotocoagulation for pediatric glaucoma. J AAPOS 1999;3:131-137
  51. Al-Haddad CE, Freedman SF: Endoscopic laser cyclophotocoagulation in pediatric glaucoma with corneal opacities. J AAPOS 2007;11:23-28
  52. Carter BC, Plager DA, Neely DE, et al: Endoscopic diode laser cyclophotocoagulation in the management of aphakic and pseudophakic glaucoma in children. J AAPOS 2007;11:34-40
  53. Egbert PR, Fiadoyor S, Budenz DL, et al: Diode laser transscleral cyclophotocoagulation as a primary surgical treatment for primary open-angle glaucoma. Arch Ophthalmol 2001;119:345-350
  54. Kramp K, Vick HP, Guthoff R: Transscleral diode laser contact cyclophotocoagulation in the treatment of different glaucomas, also as primary surgery. Graefes Arch Clin Exp Ophthalmol 2002;240:698-703
  55. Lai JS, Tham CC, Chan JC, Lam DS: Diode laser transscleral cyclophotocoagulation as primary surgical treatment for medically uncontrolled chronic angle closure glaucoma: long-term clinical outcomes. J Glaucoma 2005;14:114-119
  56. Grueb M, Rohrbach JM, Bartz-Schmidt KU, Schlote T: Transscleral diode laser cyclophotocoagulation as primary and secondary surgical treatment in primary open-angle and pseudoexfoliatve glaucoma. Long-term clinical outcomes. Graefes Arch Clin Exp Ophthalmol 2006;244:1293-1299
  57. Francis BA, Kawji AS, Vo NT, et al: Endoscopic cyclophotocoagulation (ECP) in the management of uncontrolled glaucoma with prior aqueous tube shunt. J Glaucoma 2011;20:523-527
  58. Bechrakis NE, Muller-Stolzenburg NW, Helbig H, Foerster MH: Sympathetic ophthalmia following laser cyclocoagulation. Arch Ophthalmol 1994;112:80-84
  59. Edward DP, Brown SV, Higginbotham E, et al: Sympatheticophthalmiafollowingneodymium:YAG cyclotherapy. Ophthalmic Surg 1989;20:544-546
  60. Lam S, Tessler HH, Lam BL, Wilensky JT: High incidence of sympathetic ophthalmia after contact and noncontact neodymium:YAG cyclotherapy. Ophthalmology 1992;99:1818-1822
  61. Muqit MM, Menage MJ: Malignant glaucoma after phacoemulsification: treatment with diode laser cyclophotocoagulation. J Cataract Refract Surg 2007;33:130-132
  62. Azuara-Blanco A, Dua HS: Malignant glaucoma after diode laser cyclophotocoagulation. Am J Ophthalmol 1999;127:467-469
  63. Shen SY, Lai JS, Lam DS: Necrotizing scleritis following diode laser transscleral cyclophotocoagulation. Ophthalmic Surg Lasers Imaging 2004;35:251-253


Pay-per-View Options
Direct payment This item at the regular price: USD 33.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 23.00